MedPath

Preventive effect of rebamipide on chemotherapy-induced oral mucositis in cancer patients

Not Applicable
Conditions
oral mucositis
Registration Number
JPRN-UMIN000004765
Lead Sponsor
Shimane University Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
40
Inclusion Criteria

Not provided

Exclusion Criteria

1. Patients treated with rebamipide 2. Patients with oral mucositis 3. Patients who will be treated with radiation on head and neck within the study period 4. Patients with allergy history for rebamipide

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
incidence of oral mucositis
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath